Verona Pharma plc
VRNA
|
|
| |
|
| Trading Volume | 36,300 |
|
|
28.00 - 11.49 |
| Market Cap Full | $ 16.6B |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 0.4% | -19.3% | -23.2% | -25.7% |
| Q2 | - | -5.1% | 5.3% | -16% |
| Q3 | - | 14.6% | -22.9% | 143.9% |
| Q4 | - | 16.7% | 28.5% | 155.7% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.4 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -7.7 | -6.2 | -6.8 | -1.9 | -23.2 | 25.9 | 49 | 14.6 | - | - | - | 17.3 |
| 2023 | |||||||||||
| -15.7 | -2.7 | -6.3 | 4.3 | 2.7 | -1.8 | 4.5 | -12 | -16.1 | -14.4 | -3.1 | 47 |
| 2022 | |||||||||||
| -7.6 | -9.5 | -11.2 | -14.8 | 6.6 | -7.5 | 28.5 | 93.5 | -1.9 | 25.2 | 0.8 | 102.6 |
| 2021 | |||||||||||
| 9.9 | 19 | -14.9 | -11.7 | -12.1 | 8.1 | -8 | -3.3 | -5.2 | -7.2 | -6.6 | 40.6 |
| 2020 | |||||||||||
| -1.9 | 2.9 | -27.3 | 2.9 | 12.3 | -1.7 | 45.7 | 2.8 | -11 | -5.3 | 25.7 | -5.8 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.2 | -0.4 | -0.4 | -0.9 |
| Q2 | -0.1 | -0.3 | -0.4 | -0.7 |
| Q3 | -0.2 | -0.2 | 0.2 | -0.5 |
| Q4 | 0 | -0.1 | -0.3 | 0.1 |
| A | -0.5 | -0.1 | -0.1 | -1.98 |